Skip to main content
Clinical Trials/NCT04631497
NCT04631497
Completed
Not Applicable

Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19

Jagiellonian University1 site in 1 country46 target enrollmentJuly 1, 2020
ConditionsDepression

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
Jagiellonian University
Enrollment
46
Locations
1
Primary Endpoint
Stress
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Medical personnel working in the Intensive Care Unit will be examined by means of tests. Their aim is to check how work-related stress in a potentially lethal threat affects the occurrence of depression, stress, anxiety and sleep disorders. We also want to check whether people working in such extremely difficult conditions show no greater interest in death.

Detailed Description

Every day medical staff working in very difficult conditions of intensive care. The COVID-19 virus outbreak has set another difficult task for doctors and nurses who have previously had a lot of contact with the death of their patients. The appearance of the COVID-19 virus and, above all, the inability to effectively treat the infection causes an additional psychological stimulus in medical personnel. The aim of the study is to assess the occurrence of psychiatric disorders in medical personnel dealing with patients suffering from COVID-19 using various psychological tests.

Registry
clinicaltrials.gov
Start Date
July 1, 2020
End Date
December 31, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Jagiellonian University
Responsible Party
Principal Investigator
Principal Investigator

Tomasz Skladzien

Ph.D. M.D.

Jagiellonian University

Eligibility Criteria

Inclusion Criteria

  • adult employees of the Intensive Care Unit, agreeing to undergo the tests.

Exclusion Criteria

  • patient's refusal to participate in the study
  • not understanding the test questions

Outcomes

Primary Outcomes

Stress

Time Frame: 1 month

Perceived Stress Scale (PSS) The PSS predicts both objective biological markers of stress and increased risk for disease among persons with higher perceived stress levels. For example, those with higher scores (suggestive of chronic stress) on the PSS fend worse on biological markers of aging, cortisol levels, immune markers, depression, infectious disease,wound healing, and prostate-specific antigen levels in men. PSS scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 \& 4 = 0) to the four positivelystated items (items 4, 5, 7, \& 8) and then summing across all scale items. A short 4 item scale can be made fromquestions 2, 4, 5 and 10 of the PSS 10 item scale.

Depression

Time Frame: 1 month

Beck's test the BDI-II contains 21 questions, each answer being scored on a scale value of 0 to 3. Higher total scores indicate more severe depressive symptoms. The standardized cutoffs used differ from the original: 0-13: minimal depression 14-19: mild depression 20-28: moderate depression 29-63: severe depression

Deal with Stress

Time Frame: 1 month

COPE test It is a self-written tool consisting of 60 statements, to which the respondent responds on a 4-point scale. It allows the assessment of 15 strategies for responding to stressful situations.

Secondary Outcomes

  • Stress 2(1 month)

Study Sites (1)

Loading locations...

Similar Trials